Zhejiang DiAn Diagnostics Co (300244) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥594.17 Million ≈ $86.95 Million USD) by net assets (CN¥8.67 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang DiAn Diagnostics Co (300244) total market value for the company's overall valuation and market capitalisation.
Zhejiang DiAn Diagnostics Co - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Zhejiang DiAn Diagnostics Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang DiAn Diagnostics Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang DiAn Diagnostics Co ranked by their cash flow conversion efficiency. Explore 300244 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kfin Technologies Limited
NSE:KFINTECH
|
0.108x |
|
Ennoconn Corp
TW:6414
|
0.002x |
|
Ola Electric Mobility Ltd
NSE:OLAELEC
|
-0.066x |
|
CJ Cheiljedang
KO:097950
|
0.045x |
|
Carabao Group Public Company Limited
BK:CBG
|
0.036x |
|
Guangzhou SiE Consulting Co Ltd
SHE:300687
|
0.006x |
|
Sichuan Anning Iron and Titanium Co
SHE:002978
|
-0.068x |
|
Vivendi SA
PA:VIV
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Zhejiang DiAn Diagnostics Co (2008–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang DiAn Diagnostics Co from 2008 to 2025. View Zhejiang DiAn Diagnostics Co stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.60 Billion ≈ $1.26 Billion |
CN¥2.03 Billion ≈ $296.81 Million |
0.236x | +71.17% |
| 2024-12-31 | CN¥8.77 Billion ≈ $1.28 Billion |
CN¥1.21 Billion ≈ $176.68 Million |
0.138x | -29.01% |
| 2023-12-31 | CN¥9.90 Billion ≈ $1.45 Billion |
CN¥1.92 Billion ≈ $281.15 Million |
0.194x | +12.44% |
| 2022-12-31 | CN¥9.50 Billion ≈ $1.39 Billion |
CN¥1.64 Billion ≈ $239.89 Million |
0.173x | -2.13% |
| 2021-12-31 | CN¥7.48 Billion ≈ $1.09 Billion |
CN¥1.32 Billion ≈ $192.85 Million |
0.176x | -31.31% |
| 2020-12-31 | CN¥6.03 Billion ≈ $882.20 Million |
CN¥1.55 Billion ≈ $226.41 Million |
0.257x | +172.91% |
| 2019-12-31 | CN¥5.14 Billion ≈ $751.88 Million |
CN¥483.19 Million ≈ $70.71 Million |
0.094x | +18.49% |
| 2018-12-31 | CN¥4.70 Billion ≈ $688.18 Million |
CN¥373.24 Million ≈ $54.62 Million |
0.079x | +507.28% |
| 2017-12-31 | CN¥2.95 Billion ≈ $431.21 Million |
CN¥38.51 Million ≈ $5.64 Million |
0.013x | -74.84% |
| 2016-12-31 | CN¥2.55 Billion ≈ $372.55 Million |
CN¥132.25 Million ≈ $19.35 Million |
0.052x | -58.11% |
| 2015-12-31 | CN¥1.06 Billion ≈ $154.94 Million |
CN¥131.29 Million ≈ $19.21 Million |
0.124x | -26.22% |
| 2014-12-31 | CN¥701.84 Million ≈ $102.70 Million |
CN¥117.95 Million ≈ $17.26 Million |
0.168x | +31.39% |
| 2013-12-31 | CN¥589.81 Million ≈ $86.31 Million |
CN¥75.44 Million ≈ $11.04 Million |
0.128x | +162.88% |
| 2012-12-31 | CN¥527.32 Million ≈ $77.16 Million |
CN¥25.66 Million ≈ $3.75 Million |
0.049x | +14.88% |
| 2011-12-31 | CN¥477.04 Million ≈ $69.81 Million |
CN¥20.20 Million ≈ $2.96 Million |
0.042x | -83.57% |
| 2010-12-31 | CN¥159.92 Million ≈ $23.40 Million |
CN¥41.23 Million ≈ $6.03 Million |
0.258x | +601.12% |
| 2009-12-31 | CN¥110.32 Million ≈ $16.14 Million |
CN¥4.06 Million ≈ $593.57K |
0.037x | +127.90% |
| 2008-12-31 | CN¥27.86 Million ≈ $4.08 Million |
CN¥-3.67 Million ≈ $-537.24K |
-0.132x | -- |
About Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more